Autoimmune Myasthenia Gravis
作者:
LopateGlenn,
PestronkAlan,
期刊:
Hospital Practice
(Taylor Available online 1993)
卷期:
Volume 28,
issue 1
页码: 109-131
ISSN:2154-8331
年代: 1993
DOI:10.1080/21548331.1993.11442741
出版商: Taylor&Francis
数据来源: Taylor
摘要:
The evident defect in this disease is postsynaptic dysfunction due to anti-acetylcholine receptor antibodies. The postsynaptic membrane is simplified, the number of acetylcholine receptors is reduced, and neuromuscular transmission is impaired. Antiacetylcholinesterase drugs still play a role in management. Newer options include prednisone, azathioprine, and cyclosporine.
点击下载:
PDF (1399KB)
返 回